You are here

Curriculum Vitae

Expand | Collapse

Maria Papaioannou

Professor, School of Medicine

Personal Information

- 2310994825
papaioam@auth.gr
Scopus ID56350382800
PubMed IDPapaioannou+M
Γνωστικό Αντικείμενο:
Αιματολογία
Επιστημονική Ειδίκευση: Ιατρική

Education

Προπτυχιακές Σπουδές

1985	Πτυχίο Ιατρική Α.Π.Θ. Greece Αιματολογία

Διδακτορικό Δίπλωμα

2002	ΔΔ Ιατρική Α.Π.Θ. Greece Αιματολογία

Μετεκπαίδευση

Στη Μεγ.Βρετανία με αντικείμενο Μοριακή Βιολογία, για 3 έτη.

Course Work

Courses of Winter semester of 2026–27 academic year

	SCHOOL OF DENTISTRY
100202C	Biochemistry I

	SCHOOL OF MEDICINE
ΙΑ1031	Introduction to Clinical Typology (Internal Medicine, Surgery and Pediatrics)
ΙΑ1070	Internal Medicine II
ΙΑ2019	Oral Medicine
ΙΑ2055	Hematologic Manifastations in Systematic Diseases

	INTERDEPARTMENTAL PROGRAM OF POSTGRADUATE STUDIES OF NANOSCIENCES & NANOTECHNOLOGIES
ΝΝΥ103	MOLECULAR BIOLOGY AND GENETIC ENGINEERING

Courses of Spring semester of 2026–27 academic year

	SCHOOL OF DENTISTRY
100202C	Biochemistry I
100602C	Pathology I

	SCHOOL OF MEDICINE
ΙΑ1021	Basic Clinical Skills
ΙΑ1037	Pathological Physiology
ΙΑ1047	Internal Medicine I
ΙΑ1070	Internal Medicine II

	POSTGRADUATE STUDIES PROGRAMME "PRECISION MEDICINE - TRANSLATION RESEARCH AND THERAPEUTICS"
ΙΑΒ02	Personalised diagnosis and therapy

Theses Supervised

Student Theses within AUTh

Unknown

Postgraduate

No title
Real world data on the use of PD-1 inhibitors in classical Hodgkin’s Lymphoma

2025–2026

Postgraduate

Hematological Profile of Newly Diagnosed HIV-Positive Patients: A Retrospective Cohort Study.

2024–2025

Postgraduate

The role of telocytes in pathophysiology and therapeutics of skin diseases

Doctoral

No title

2023–2024

Postgraduate

No title

Doctoral

No title

2022–2023

Postgraduate

CRISPR-Cas9: future applications, legal and ethical challenges concerning genome modification
Isolation of adipose tissue stem cells and control of their survival time
Study of SARS CoV 2 vaccination in Chronic Lymphocytic Leukemia patients

Doctoral

No title

2020–2021

Postgraduate

Prothrombin complex concentrate in major bleeding associated with DOACs; Off label or standard of care? An updated systematic review and meta-analysis

2016–2017

Postgraduate

Pathogen-specific T-cell reconstitution in patients undergoing allogeneic hematopoietic stem cell transplantation

2013–2014

Postgraduate

No title

2010–2011

Postgraduate

No title

In progress

Doctoral

No title
No title
No title
No title
No title
No title
No title
No title
No title

2018–2019

Doctoral

No title

2017–2018

Doctoral

No title

Theses outside AUTh

Doctoral Level

Λυδία Κυριαζοπούλου. , Πανεπιστήμιο Ιωαννίνων.

Research Projects

Coordinator
2025–2030	A Phase 3 Randomized, Double-blind, Placebo-controlled, Study of Bleximenib, Venetoclax and Azacitidine for the Treatment of Participants with Newly Diagnosed Acute Myeloid Leukemia Harboring KMT2ARearrangements or NPM1Mutations who are Ineligible for Intensive Chemotherapy
2022–2025	A RAndomized, Open-Label Study of the Efficacy and Safety of Galinpepimut-S (GPS) Maintenance Monotherapy Compared to Investigator's Choice of Best Available Therapy in Subjects with Acute Myeloid Leukemia Who Have Achieved Complete Remission After Second-Line Salvage Therapy
2022–2025
2018–2024	Clinical hematology
2018–2020	Efficacy of daratumumab in patients with relapsed/refractory myeloma with renal impairment (DARE)
2018–2021	A prospective, multicenter, non-comparative, open-label, phase II study to evaluate the effects of daratumumab monotherapy on bone parametersin patients with relapsed and/or refractory multiple myeloma who have received at least 2 prior lines of therapy including lenalidomide and a proteasome inhibitor (REBUILD)
2018–2020	A retrospective chart review and a prospective study of the pomalidomide plus low dose dexamethasone efficacy in relapsed/refactory multiple myeloma patients under real-life conditions (POWERFUL)
2015–2018	A non interventional observational study/registry of paroxysmal nocturnal hemoglobinuria- PNH Registry
2014–2017	Prospect observational study of febrile neutropenia (FN) and pegfilgrastim primary prophylaxis in patients with breast cancer and non - Hodgkin lymphoma receiving chemotherapy associated with high (> 20%) risk of febrile neutropenia.
2014–2026	Educational lectures - chairing of round tables consulations of educational chapter in hematology
2013–2013	Managemnent of febril neutropenia in patients with hematologic malignancies, a case report
2009–2026	Molecular genetics in haematologic diseases

Participant
2020–2028	Precision Medicine-Translational Research and therapeutics
2019–2026
2015–2020	MSc in Medical Research Methodology
1999–2026

Updated: 2026-09-30